# G0 Post-G12 Closeout Synthesis - 2026-05-06

**Lane:** `G0`  
**Status:** `G0_POST_G12_CLOSEOUT_COMPLETE_RESEARCH_CONTROL_ONLY`  
**Checked at UTC:** `2026-05-06T12:08:31Z`  
**HEAD read:** `64135c3a`  
**Promotion verdict:** `NO_PROMOTION_VERDICT`

## Objective Restated

Close the G0 primitive-science research program after G12 red-team review. The closeout reconciles the G12 decisions into final program status, without promoting any row, opening any outcome review, clearing any source, changing survivor backlog count, or touching live trading behavior.

## Evidence Base

G0 completed mandatory preflight and read the current control set:

- `.context/LIVE_STATE.md` regenerated from `python scripts/generate_live_state.py`.
- Latest handoff: `.context/02_session_handoffs/SESSION_54_WEEKEND_GOAL_HANDOFF_2026-05-02.md`.
- `.context/00_core/quick_reference_card.md`.
- `.context/00_core/research_operating_doctrine.md`.
- `.context/00_core/research_current_state.md`.
- `.context/00_READING_ORDER.md`.
- `research/science_program_2026_05/04_goal_prompts/G0_G0_PROGRAM_GOVERNOR_GOAL_PROMPT_2026-05-06.md`.
- HEAD `64135c3a docs: record g12 science red-team state`.
- G12 red-team review, survivor/blocker decisions, leakage ledger, duplicate-counting review, label-separation review, and source-validity review.
- G0 CD2 reconciliation, master registry, experiment preregistry, source-contract registry, goal-status registry, and source-budget ledger.

## Final Registry State

| Registry | Rows | Post-G12 status |
| --- | ---: | --- |
| Mechanisms | `77` | Unchanged. No mechanism row promoted or added by G12. |
| Hypotheses | `96` | Unchanged. G11 no-leak blockers remain enforced. |
| Experiment preregs | `97` | Unchanged. Two CD2 preregs remain outcome-closed research-control rows only. |
| Source contracts | `86` | Unchanged. `validation_safe=true` remains `0`. |
| Survivor backlog | `0` | Unchanged. No survivor-backlog row exists. |

## Final Program Verdict

The primitive-science program is complete for the G0/G12 research-control closeout scope and remains research-only. The final state is:

- `survivor_backlog_rows=0`.
- `validation_safe_true_sources=0`.
- `outcome_review_opened_true_preregs=0`.
- Accepted CD2 preregs remain `outcome_review_opened=false`.
- No source contract is validation-safe.
- No CD2 assignment is promotable.
- All standing wave-2 and CD2 blockers remain enforced.
- Source budget remains `$0` new external cash spend with no per-source approval.
- No live trading prompt, risk, execution, permissions, safety-gate, selector, MT5, canary, paid-data, credential, remote, or order-behavior surface was touched.

## G12 Decision Reconciliation

| Assignment | Final G0 post-G12 status | Effect on master rows |
| --- | --- | --- |
| `CD2-01` | `BLOCKED_SOURCE_FRESHNESS_ASOF` | No row promotion. Source-specific parser/cache/publication/vintage/no-lookahead tests required. |
| `CD2-02` | `SURVIVES_RESEARCH_ONLY_OUTCOME_CLOSED` | Existing accepted prereg survives only as research-control inventory. Outcome review stays closed. |
| `CD2-03` | `SURVIVES_RESEARCH_ONLY_OUTCOME_CLOSED_WITH_LEDGER_NAMING_BLOCKER` | Existing accepted prereg survives only as research-control inventory. Risk-bank ledger naming blocker remains. |
| `CD2-04` | `STATUS_ONLY_SOURCE_PROVENANCE_SURVIVES_RAW_FEATURES_BLOCKED` | Status/provenance guidance only. No raw orderflow/depth predictive features or source validation flip. |
| `CD2-05` | `BLOCKED_DUPLICATE_AND_SOURCE_PATH_CLEANUP` | No machine-readable master row until canonical row, source path cleanup, stale-calendar handling, Fed parser, and effective-N policy exist. |
| `CD2-06` | `STATUS_ONLY_CAPTURE_SPEC_SURVIVES_ANALYSIS_BLOCKED` | Capture spec is useful, but current rows are not analysis-ready. No path/no-retrace/fill-quality validation. |
| `CD2-07` | `BLOCKED_SIDECAR_ONLY_NOT_MASTER_REGISTERED` | Sidecar remains outside the master registry. No opportunity-cost value/R outcome opens. |
| `CD2-08` | `ACCEPT_AS_FUTURE_CLEANUP_GUIDANCE_NO_MASTER_EDIT_NOW` | Cleanup guidance accepted for a future G0/G12-controlled pass only. No registry edit in this closeout. |

## Accepted CD2 Preregs

| Experiment | Final status | Required future blockers before any outcome review |
| --- | --- | --- |
| `EXP-G8-CD2-02-SHORTVOL-LIFECYCLE-001` | Research-only, outcome-closed lifecycle prereg | Cboe publication-as-of proof, lifecycle ordering, source hashes/parser versions, duplicate lifecycle tests, implementation label-separation checks. |
| `EXP-G9-CD2-03-OFFLINE-RL-RISKBANK-001` | Research-only, outcome-closed offline-RL prereg | Label-specific risk-bank ledger fields, behavior policy freeze, duplicate episode IDs, cost model, same-bar handling, sample floors, G1 DSR/PBO/effective-N gates. |

## Standing Blockers Preserved

- G11 no-leak semantic inversion remains a hard blocker for outcome opening and promotion.
- Unregistered source placeholders and literature references remain hard source-validity blockers.
- Broker actual-R scarcity remains a hard blocker for actual-R claims.
- Macro/vol publication leakage remains a hard blocker for source feature use.
- Execution/path label separation remains a hard blocker for analysis and promotion.
- Old G6 label-class normalization residue remains a schema-hygiene blocker for direct lane-row consumption.
- Global `validation_safe=false` boundary remains preserved.

## Completion State

G0 closeout is complete as research-control synthesis only. The program has a clear backlog/readiness map, blocker-to-next-action map, source/no-leak cleanup assignment list, and completion audit. No promotion or live change is authorized.

## NO_PROMOTION_VERDICT

This closeout is a governance artifact. It validates no trading edge, opens no outcome review, clears no source, adds no survivor row, and changes no live trading behavior.
